ArticleBMJ open2026
Thyroid dysfunction and its associated factors: a cross-sectional study based on Rafsanjan cohort study in the southeast of Iran.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study aimed to determine the prevalence and associated factors with thyroid dysfunction within a large cohort participating in the Rafsanjan Cohort Study (RCS), part of the Prospective Epidemiological Research Studies in Iran (PERSIAN). STUDY
designA cross-sectional study based on RCS.
settingThe study was carried out in Rafsanjan, a region in the southeast of Iran.
participantsParticipants were chosen using a cluster sampling technique. A total of 9991 participants between the ages of 35 and 70 years from both genders participated in the initial phase of the RCS. OUTCOMES: Thyroid dysfunction was determined based on self-reported diagnosis.
methodsThe association of thyroid dysfunction with gender, age, body mass index (BMI), physical activity, substance use, education and Wealth Score Index (WSI) was assessed using multivariable logistic regression.
resultsAmong 9867 participants, thyroid dysfunction prevalence was 8.98%. Women had 6.56 times higher odds compared with men (OR: 6.56, 95%CI 5.03 to 8.55). BMI ≥30 had 22% higher odds compared with BMI <25 (OR: 1.22, 95% CI 1.01 to 1.50). Middle high WSI and high WSI were positively associated with thyroid dysfunction (OR: 1.35, 95% CI 1.11 to 1.65 and OR: 1.61, 95% CI 1.17 to 2.23, respectively). Former smoking was associated with increased odds of thyroid dysfunction (OR: 1.65, 95% CI 1.14 to 2.38). Age groups 46-55 years and ≥56 years exhibited higher odds of hypothyroidism compared with 35-45 years (OR: 1.47, 95% CI 1.15 to 1.87 and OR: 1.61, 95% CI 1.24 to 2.09, respectively).
conclusionThis study shows the elevated burden of thyroid dysfunction among women and older adults and highlights modifiable associated factors such as BMI and smoking history. These findings emphasise the need for targeted screening and lifestyle interventions in high-risk groups. Future longitudinal studies are warranted to elucidate causal pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.